Cargando…

The mental health associations of vitiligo: UK population-based cohort study

BACKGROUND: Vitiligo is an acquired, autoimmune depigmenting skin disorder that may affect psychological well-being. AIMS: To determine the risk and impact of psychological comorbidity in people with new-onset vitiligo. METHOD: We conducted a retrospective observational study, using UK general pract...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Andrew R., Eleftheriadou, Viktoria, Nesnas, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634603/
https://www.ncbi.nlm.nih.gov/pubmed/36268886
http://dx.doi.org/10.1192/bjo.2022.591
_version_ 1784824531209158656
author Thompson, Andrew R.
Eleftheriadou, Viktoria
Nesnas, John
author_facet Thompson, Andrew R.
Eleftheriadou, Viktoria
Nesnas, John
author_sort Thompson, Andrew R.
collection PubMed
description BACKGROUND: Vitiligo is an acquired, autoimmune depigmenting skin disorder that may affect psychological well-being. AIMS: To determine the risk and impact of psychological comorbidity in people with new-onset vitiligo. METHOD: We conducted a retrospective observational study, using UK general practice data (2004–2020). Adults diagnosed with vitiligo (n = 7224) were matched 1:4 with controls (n = 28 880). Associations within 2 years of diagnosis were assessed for psychological conditions: recurrent depressive disorder (RDD), depressive episodes, non-phobia-related anxiety disorder, social phobia, adjustment disorder, substance misuse, self-harm and suicide attempts. Healthcare utilisation, time off work and unemployment within 1 year were compared in those with and without a mental health condition at vitiligo diagnosis. RESULTS: At diagnosis, people with vitiligo had a similar prevalence of mental health conditions as controls, except for anxiety disorder (cases 7.9%, controls 7.0%; P = 0.014). Incident RDD and anxiety disorder were more common in people with vitiligo (RDD: adjusted hazard ratio (aHR) 1.25, 95% CI 1.01–1.55; anxiety disorder: aHR 1.23, 95% CI 1.00–1.51). Risk was highest in Black and minority ethnic individuals (RDD: aHR 1.72, 95% CI 1.06–2.79; depressive episodes: aHR 1.56, 95% CI 1.03–2.37). No association was found with other mental health conditions. People with vitiligo and psychological comorbidity had more primary care encounters, more time off workand higher unemployment. CONCLUSIONS: People with vitiligo have a higher incidence of RDD and anxiety disorder than controls, and this risk increase may be greatest in Black and minority ethnic populations.
format Online
Article
Text
id pubmed-9634603
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-96346032022-11-21 The mental health associations of vitiligo: UK population-based cohort study Thompson, Andrew R. Eleftheriadou, Viktoria Nesnas, John BJPsych Open Paper BACKGROUND: Vitiligo is an acquired, autoimmune depigmenting skin disorder that may affect psychological well-being. AIMS: To determine the risk and impact of psychological comorbidity in people with new-onset vitiligo. METHOD: We conducted a retrospective observational study, using UK general practice data (2004–2020). Adults diagnosed with vitiligo (n = 7224) were matched 1:4 with controls (n = 28 880). Associations within 2 years of diagnosis were assessed for psychological conditions: recurrent depressive disorder (RDD), depressive episodes, non-phobia-related anxiety disorder, social phobia, adjustment disorder, substance misuse, self-harm and suicide attempts. Healthcare utilisation, time off work and unemployment within 1 year were compared in those with and without a mental health condition at vitiligo diagnosis. RESULTS: At diagnosis, people with vitiligo had a similar prevalence of mental health conditions as controls, except for anxiety disorder (cases 7.9%, controls 7.0%; P = 0.014). Incident RDD and anxiety disorder were more common in people with vitiligo (RDD: adjusted hazard ratio (aHR) 1.25, 95% CI 1.01–1.55; anxiety disorder: aHR 1.23, 95% CI 1.00–1.51). Risk was highest in Black and minority ethnic individuals (RDD: aHR 1.72, 95% CI 1.06–2.79; depressive episodes: aHR 1.56, 95% CI 1.03–2.37). No association was found with other mental health conditions. People with vitiligo and psychological comorbidity had more primary care encounters, more time off workand higher unemployment. CONCLUSIONS: People with vitiligo have a higher incidence of RDD and anxiety disorder than controls, and this risk increase may be greatest in Black and minority ethnic populations. Cambridge University Press 2022-10-21 /pmc/articles/PMC9634603/ /pubmed/36268886 http://dx.doi.org/10.1192/bjo.2022.591 Text en © Pfizer Limited 2022 https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike licence (http://creativecommons.org/licenses/by-nc-sa/4.0), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the same Creative Commons licence is used to distribute the re-used or adapted article and the original article is properly cited. The written permission of Cambridge University Press must be obtained prior to any commercial use.
spellingShingle Paper
Thompson, Andrew R.
Eleftheriadou, Viktoria
Nesnas, John
The mental health associations of vitiligo: UK population-based cohort study
title The mental health associations of vitiligo: UK population-based cohort study
title_full The mental health associations of vitiligo: UK population-based cohort study
title_fullStr The mental health associations of vitiligo: UK population-based cohort study
title_full_unstemmed The mental health associations of vitiligo: UK population-based cohort study
title_short The mental health associations of vitiligo: UK population-based cohort study
title_sort mental health associations of vitiligo: uk population-based cohort study
topic Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634603/
https://www.ncbi.nlm.nih.gov/pubmed/36268886
http://dx.doi.org/10.1192/bjo.2022.591
work_keys_str_mv AT thompsonandrewr thementalhealthassociationsofvitiligoukpopulationbasedcohortstudy
AT eleftheriadouviktoria thementalhealthassociationsofvitiligoukpopulationbasedcohortstudy
AT nesnasjohn thementalhealthassociationsofvitiligoukpopulationbasedcohortstudy
AT thompsonandrewr mentalhealthassociationsofvitiligoukpopulationbasedcohortstudy
AT eleftheriadouviktoria mentalhealthassociationsofvitiligoukpopulationbasedcohortstudy
AT nesnasjohn mentalhealthassociationsofvitiligoukpopulationbasedcohortstudy